Cholesterol and Lipid Disorders: Key Messages in Diagnosis and Management

Date(s):
Thursday 5 October 2023
1pm - 2.20pm

Location: Online
Organised by: Health Innovation West of England
Tel: n/a
Email: jelena.ivanovic@nhs.net

Event summary

Health Innovation West of England (formerly the West of England AHSN) is providing a series of 80-minute online education sessions for GPs and Health Care Professionals on the management of patients with high cholesterol and lipid disorders.

Delivered by secondary care consultants and pharmacists, this virtual session will be 80 minutes and include time for questions and discussion.

Treating high cholesterol is a priority in the NHS Long Term Plan, as it will have a major impact on Cardio Vascular Disease (CVD) which currently accounts for 25% of UK deaths and is the main cause of death in deprived areas.

This session (which will be repeated on multiple dates) will cover the optimisation of treatment of patients with established CVD, including the use of high intensity statins and ezetimibe, when to refer to secondary care and the secondary care prescribing options available. It will also cover the proactive identification of patients with Familial Hypercholesterolaemia (FH).

There will be time for questions and case studies after the first hour of the webinar. If you have already attended another of these webinars, you may want to join the last 20 minutes of a session to discuss anonymised cases you have come across. If you will only be attending the final 20 minutes, please register here: 20 Minute-Case Study Only Registration Form (zohopublic.eu)

Please note that the sessions will only run if a minimum number sign up. Where there are not enough signups, you will be automatically registered for the next session

These events relate to the AHSN Network’s FH and Lipids Programme and work to increase usage of a series of Rapid Uptake Products. The webinars will reference the local pathways developed within the West of England (BSW, BNSSG and Gloucestershire) which are consistent with the NICE-approved lipid management pathway. Thus, specific questions about systems in other regions cannot be answered, but we will signpost you to the relevant organisation if necessary.

Book now


> Back to index

Search events